These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14724049)

  • 21. Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice.
    Liu YL; Connoley IP; Wilson CA; Stock MJ
    Int J Obes (Lond); 2005 Feb; 29(2):183-7. PubMed ID: 15558076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats.
    Sink KS; Segovia KN; Nunes EJ; Collins LE; Vemuri VK; Thakur G; Makriyannis A; Salamone JD
    Psychopharmacology (Berl); 2009 Oct; 206(2):223-32. PubMed ID: 19588124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis.
    Hsiao WC; Shia KS; Wang YT; Yeh YN; Chang CP; Lin Y; Chen PH; Wu CH; Chao YS; Hung MS
    Diabetes Obes Metab; 2015 May; 17(5):495-504. PubMed ID: 25656402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of rimonabant, a cannabinoid CB1 receptor ligand, on energy expenditure in lean rats.
    Kunz I; Meier MK; Bourson A; Fisseha M; Schilling W
    Int J Obes (Lond); 2008 May; 32(5):863-70. PubMed ID: 18253160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A neutral CB1 receptor antagonist reduces weight gain in rat.
    Chambers AP; Vemuri VK; Peng Y; Wood JT; Olszewska T; Pittman QJ; Makriyannis A; Sharkey KA
    Am J Physiol Regul Integr Comp Physiol; 2007 Dec; 293(6):R2185-93. PubMed ID: 17959701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake.
    Thornton-Jones ZD; Kennett GA; Benwell KR; Revell DF; Misra A; Sellwood DM; Vickers SP; Clifton PG
    Pharmacol Biochem Behav; 2006 Jun; 84(2):353-9. PubMed ID: 16814374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.
    Patel KN; Joharapurkar AA; Patel V; Kshirsagar SG; Bahekar R; Srivastava BK; Jain MR
    Can J Physiol Pharmacol; 2014 Dec; 92(12):975-83. PubMed ID: 25361428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation.
    Zhang L; Lee NJ; Nguyen AD; Enriquez RF; Riepler SJ; Stehrer B; Yulyaningsih E; Lin S; Shi YC; Baldock PA; Herzog H; Sainsbury A
    Diabetes Obes Metab; 2010 Jul; 12(7):591-603. PubMed ID: 20590734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions.
    Salamone JD; McLaughlin PJ; Sink K; Makriyannis A; Parker LA
    Physiol Behav; 2007 Jul; 91(4):383-8. PubMed ID: 17521686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cannabinoid receptors on skeletal muscle oxidative pathways.
    Cavuoto P; McAinch AJ; Hatzinikolas G; Cameron-Smith D; Wittert GA
    Mol Cell Endocrinol; 2007 Mar; 267(1-2):63-9. PubMed ID: 17270342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects on food intake and blood lipids of cannabinoid receptor 1 antagonist treatment in lean rats.
    Bennetzen MF; Nielsen MP; Richelsen B; Pedersen SB
    Obesity (Silver Spring); 2008 Nov; 16(11):2451-5. PubMed ID: 18719671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat.
    Bojanowska E; Radziszewska E
    J Physiol Pharmacol; 2011 Aug; 62(4):395-402. PubMed ID: 22100840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonism of peripheral hepatic cannabinoid receptor-1 improves liver lipid metabolism in mice: evidence from cultured explants.
    Jourdan T; Demizieux L; Gresti J; Djaouti L; Gaba L; Vergès B; Degrace P
    Hepatology; 2012 Mar; 55(3):790-9. PubMed ID: 21987372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CB1 cannabinoid receptor-mediated modulation of food intake in mice.
    Wiley JL; Burston JJ; Leggett DC; Alekseeva OO; Razdan RK; Mahadevan A; Martin BR
    Br J Pharmacol; 2005 Jun; 145(3):293-300. PubMed ID: 15778743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade.
    Crespillo A; Suárez J; Bermúdez-Silva FJ; Rivera P; Vida M; Alonso M; Palomino A; Lucena MA; Serrano A; Pérez-Martín M; Macias M; Fernández-Llébrez P; Rodríguez de Fonseca F
    Biochem J; 2011 Jan; 433(1):175-85. PubMed ID: 20955176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of exercise and food restriction on obesity and diabetes in young ob/ob mice.
    Dubuc PU; Cahn PJ; Willis P
    Int J Obes; 1984; 8(3):271-8. PubMed ID: 6378818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats.
    Sink KS; Segovia KN; Collins LE; Markus EJ; Vemuri VK; Makriyannis A; Salamone JD
    Pharmacol Biochem Behav; 2010 Jun; 95(4):479-84. PubMed ID: 20347865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats.
    Mathes CM; Ferrara M; Rowland NE
    Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R67-75. PubMed ID: 18448611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of phenylpropanolamine on food intake and body weight in the genetically obese (ob/ob) mouse.
    Wellman PJ; Miller J
    Appetite; 1987 Dec; 9(3):231-6. PubMed ID: 3435138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Voluntary running decreases nonexercise activity in lean and diet-induced obese mice.
    de Carvalho FP; Benfato ID; Moretto TL; Barthichoto M; de Oliveira CA
    Physiol Behav; 2016 Oct; 165():249-56. PubMed ID: 27497922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.